par Sunshine Biopharma Inc.
NASDAQ: SBFM ð¥ Enters Into A Collaboration Agreement For Its K1.1 Anticancer mRNA Project! ð¬
EQS-News: Sunshine Biopharma Inc.
NASDAQ: SBFM ðÂÂÂ¥ Enters Into A Collaboration Agreement For Its K1.1 Anticancer mRNA Project! ð¬
23.11.2022 / 17:20 CET/CEST
The issuer is solely responsible for the content of this announcement.
Contact DetailsChristine Petraglia - TraDigital IR
+1 917-633-8980
investors@sunshinebiopharma.com
Company Websitehttps://sunshinebiopharma.com/
News Source: News Direct
23.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Sunshine Biopharma Inc. |
| United States | |
| ISIN: | US8677812054 |
| EQS News ID: | 1495061 |
| End of News | EQS News Service |
1495061 23.11.2022 CET/CEST